Bringing the fundamentals into focus…
Back to Inhibrx Biosciences, Inc.
How Inhibrx Biosciences, Inc. stacks up
INBX · against 456 other Healthcare companies of similar size
Overall
6/ 100
Near the bottom of its peers.
Ranked #454 of 457 · scores higher than 0% of peers
Bars: peers in each 10-point band of the overall score6 peers with an overall score of 0–9, including INBX · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around INBX| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 1 | 15.6B DKK (≈$2.3B) | 96 | 96 | 99 | 96 | 0 / 2 | |
| 3 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 4 | 609M USD | 91 | 95 | 99 | 99 | 0 / 2 | |
| 5 | 2.29T KRW (≈$1.6B) | 88 | 83 | 90 | 96 | 0 / 2 | |
| 451 | 14.2B CNY (≈$2.0B) | 10 | 0 | 12 | 23 | 2 / 2 | |
| 452 | 5.2B CNY (≈$723M) | 9 | 0 | 5 | 29 | 2 / 2 | |
| 453 | 1.6B USD | 7 | 8 | 0 | 18 | 2 / 2 | |
| 454 | 2.4B USD | 6 | 8 | — | 8 | 2 / 2 | |
| 454 | 1.2B USD | 6 | 8 | 11 | 0 | 2 / 2 | |
| 456 | 1.2B USD | 3 | 0 | — | 3 | 2 / 2 | |
| 456 | 952M USD | 3 | 0 | 5 | 0 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score